Tigenix N.V. – Trademark Portfolio

Entity Type: 03

Tigenix N.V. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 5 Nice Classification classes. The owner is based in Leuven.

Leuven 3001 , BE

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CCI
CCI
Cancelled 2007
CCI
CCI
Cancelled 2007
TIGENIX
TIGENIX
Cancelled 2000

Trademark Classifications

Tigenix N.V.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (4 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (3 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Tigenix N.V. have?

Tigenix N.V. has 5 U.S. trademarks filed with the USPTO.

What trademark classes does Tigenix N.V. file in?

Tigenix N.V. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Tigenix N.V.'s trademark registration success rate?

Tigenix N.V. has a 0% trademark registration rate, with 0 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.